WHO Seeks Clarity on Child ‘Pneumonia Clusters’ in China: Urges Protective Measures

WHO Seeks Clarity on Child 'Pneumonia Clusters' in China Urges Protective Measures

Amid reports of “clusters of undiagnosed pneumonia” affecting children in northern China, the World Health Organization (WHO) has formally requested more information from Chinese authorities. Non-state media has highlighted overwhelmed pediatric hospitals in certain regions, prompting concerns.

Zhifei Secures Exclusive Rights to Distribute GSK’s Shingles Vaccine in China

Zhifei Secures Exclusive Rights to Distribute GSK's Shingles Vaccine in China

The recent deal between China’s leading vaccine company, Zhifei, and British drugmaker GSK marks a significant move in Western pharmaceutical firms’ efforts to penetrate China’s pharmaceutical market. Valued at 2.5 billion pounds ($3.05 billion), this agreement grants Zhifei exclusive distribution rights for GSK’s top-selling shingles vaccine, Shingrix, in the second-largest pharmaceutical market globally.